<?xml version="1.0" encoding="UTF-8"?>
<p>During a pandemic, the potential for benefit with chemotherapy would be unchanged, but the risk of harm would be increased to a degree that cannot be readily quantified. Patients who underwent chemotherapy or surgery in the month before diagnosis with COVID‚Äê19 had a numerically higher risk (three of four patients) of clinically severe events than did those not receiving chemotherapy or surgery (six of 14 patients) 
 <xref rid="onco13306-bib-0007" ref-type="ref">7</xref>.
</p>
